Q32 Bio Market Cap

Q32 Bio has a market cap or net worth of $290.84 million as of April 18, 2024. Its market cap has increased by 404.93% in one year.

Market Cap

290.84M

Enterprise Value

208.31M

1-Year Change

404.93%

Ranking

#3361

Market Cap Chart

Since March 28, 2018, Q32 Bio's market cap has decreased from $673.30M to $290.84M, a decrease of -56.80%. That is a compound annual growth rate of -12.93%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2024	77.90M	-3.47%
Apr 16, 2024	80.70M	-5.50%
Apr 15, 2024	85.40M	-8.47%
Apr 12, 2024	93.30M	21.33%
Apr 11, 2024	76.90M	10.81%
Apr 10, 2024	69.40M	0.87%
Apr 9, 2024	68.80M	-0.58%
Apr 8, 2024	69.20M	5.97%
Apr 5, 2024	65.30M	-2.39%
Apr 4, 2024	66.90M	-2.76%
Apr 3, 2024	68.80M	-3.10%
Apr 2, 2024	71.00M	22.20%
Apr 1, 2024	58.10M	5.64%
Mar 28, 2024	55.00M	5.36%
Mar 27, 2024	52.20M	-2.97%
Mar 26, 2024	53.80M	-0.92%
Mar 25, 2024	54.30M	0.74%
Mar 22, 2024	53.90M	4.86%
Mar 21, 2024	51.40M	-2.28%
Mar 20, 2024	52.60M	0.57%
Mar 19, 2024	52.30M	-
Mar 18, 2024	52.30M	-1.69%
Mar 15, 2024	53.20M	-1.30%
Mar 14, 2024	53.90M	1.89%
Mar 13, 2024	52.90M	1.73%

View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
TriSalus Life Sciences	292.56M
Sutro Biopharma	292.30M
Kamada	291.97M
Akebia Therapeutics	291.03M
Monte Rosa Therapeutics	290.89M
Inozyme Pharma	287.24M
Pulmonx	286.33M
Prelude Therapeutics	283.28M

Market Cap Rankings